form8k.htm


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

Current Report
 
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of report (date of earliest event reported):  April 30, 2012

Balchem Corporation
(Exact name of registrant as specified in its charter)

Maryland
1-13648
13-257-8432
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer Identification No.)

52 Sunrise Park Road, New Hampton, NY 10958
(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (845) 326-5600

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))



 
 

 
 
Item 7.01
Regulation FD Disclosure

Balchem Corporation today announced plans for a new manufacturing facility in Allegheny County, Virginia. A copy of the press release is furnished as Exhibit 99.1 to this Report.

The information in this Form 8-K (including Exhibit 99.1) shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such a filing.
 
Item 9.01 
Financial Statements and Exhibits.

(c)  Exhibits

Exhibit 99.1
Press Release of Balchem Corporation, dated April 30, 2012.
 
 
 

 
 
SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
BALCHEM CORPORATION
 
       
  By:/s/ Dino A. Rossi
 
Dino A. Rossi, President &
 
 
Chief Executive Officer
 
       
Dated: April 30, 2012
     
 
 
 

 
 
Exhibit Index
 
Exhibit Number
Description
   
Press Release of Balchem Corporation, dated April 30, 2012.